New Zealand’s central bank yesterday raised interest rates by half a percentage point, its biggest hike in 22 years, indicating it is worried that inflation is getting out of control.
The Reserve Bank of New Zealand’s (RBNZ) Monetary Policy Committee lifted the official cash rate (OCR) to 1.5 percent from 1 percent, the first time it has delivered an increase of that magnitude since 2000.
“The committee agreed that their policy ‘path of least regret’ is to increase the OCR by more now, rather than later, to head off rising inflation expectations,” the RBNZ said. “It is appropriate to continue to tighten monetary conditions at pace.”
Photo: Reuters
The central bank has raised the cash rate for four straight policy meetings, lifting it by 125 basis points since October last year, as inflation surged to a 32-year high. The risk is that the rapid rise in borrowing costs could stall the economy. House prices are already falling, and business and consumer confidence have slumped amid New Zealand’s worst COVID-19 outbreak.
“The RBNZ’s decision to accelerate its hiking cycle shows it is willing to move decisively to get a hand on surging inflation,” said Ben Udy, an economist at Capital Economics in Singapore. “We expect it to hike the OCR to 3 percent by the end of this year.”
In its statement, the RBNZ said it remains comfortable with the forward track for the cash rate it published in February, indicating it sees no need to take rates higher than the 3.25 percent peak it forecast for the end of next year.
However, it said it wants to get the OCR “to a more neutral stance sooner.”
It estimates a neutral level for the cash rate is about 2 percent.
“The committee noted that the OCR is stimulatory at its current level,” it said. “Members noted that annual consumer price inflation is expected to peak around 7 percent in the first half of 2022. The risk of more persistent high inflation expectations has increased.”
The RBNZ aims to keep inflation around the middle of a 1 to 3 percent target range.
New Zealand is at the forefront of global policy tightening as central banks around the world respond to an inflation surge that is threatening to become entrenched. The Bank of Canada was expected to raise its key rate by half a point to 1 percent later yesterday, while the Bank of Korea might add to its three rate hikes today.
The US Federal Reserve began its tightening cycle last month and its policymakers have signaled they could move in half-point steps if needed. The Reserve Bank of Australia this month opened the door to rate increases, with economists tipping its first hike would come in early June.
“Heightened global economic uncertainty and inflation are dampening consumer confidence,” the RBNZ said. “The rise in mortgage interest rates — amongst other factors — have acted to reduce mortgage demand and house prices.”
Russia’s invasion of Ukraine is worsening inflation by driving up commodity prices, while also hurting confidence and dampening the economic outlook.
“A larger move now also provides more policy flexibility ahead in light of the highly uncertain global economic environment,” the RBNZ said.
UNCONVINCING: The US Congress questioned whether the company’s Chinese owners pose a national security risk and how the app might influence young users TikTok chief executive officer Shou Chew (周受資), confronted with an unforgiving, distrustful US Congress, tried to give answers in his testimony on Thursday that avoided offending either the US government or China. However, his evasiveness left Congress unsatisfied, with representatives hungrier than ever to punish TikTok for ties to its parent company ByteDance Ltd (字節跳動), based in Beijing. He did not bring his company any closer to a resolution. Politically, TikTok is in a tougher spot. Its executives had been discussing divesting from ByteDance to resolve US national security concerns, people familiar with the matter told Bloomberg. However, China this week said
Sanofi SA’s drug Dupixent succeeded in a late-stage trial for chronic obstructive pulmonary disease (COPD), raising the odds that the blockbuster would be the first biologic medicine cleared to treat the lung disorder. Dupixent, which is already prescribed for asthma and some skin conditions, showed a 30 percent reduction in the rate at which patients’ COPD worsened compared with those who received a placebo during the stage-three Boreas trial, the company said in a statement yesterday. The positive data could herald a new era of cutting-edge treatments for the life-threatening respiratory affliction and provide another major boost in demand for the French
SEMICONDUCTOR EQUIPMENT: The international trade group said the sector would recover from a slump, with spending expected to rise 4.2 percent to US$24.9 billion Taiwan is to retain its position as the top spender on semiconductor front-end equipment and facilities next year, with spending expected to increase 4.2 percent year-on-year to US$24.9 billion, international trade group SEMI said yesterday. The spending forecast matches an expected recovery in global semiconductor equipment and facilities investment next year, it said. International equipment spending is to return to growth next year, SEMI said in a report, forecasting 21 percent growth to US$92 billion. The expansion would manly be driven by robust demand for semiconductors in the automotive and high-performance computing segments, the association said. “This quarter’s SEMI World Fab Forecast update
Microsoft Corp has threatened to cut off access to its Internet search data, which it licenses to rival search engines, if they do not stop using it as the basis for their own artificial intelligence (AI) chat products, people familiar with the dispute have said. The software maker licenses the data in its Bing search index — a map of the Internet that can be quickly scanned in real time — to other companies that offer Web search, such as Apollo Global Management Inc’s Yahoo and DuckDuckGo. Last month, Microsoft integrated a cousin of ChatGPT, OpenAI’s AI-powered chat technology, into Bing. Rivals